Application of exosome metabolite as bipolar affective disorder marker
A bipolar disorder, metabolite technology, used in biology and medicine, to address issues such as differences in diagnostic results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0117] Subjects were 32 patients with double-phase emotional disorders accused by the Third People's Hospital of Foshan, and recruited 40 healthy volunteers that were aged and gender-matched as a control. In addition, 31 patients with depression and 42 patients with schizophrenia were also included. All physicians involved in diagnosis have a psychiatric practitioner qualification and have more than 10 years of psychiatrics experience. Skilled using SCID-1 checklists, master the ICD-10 and DSM-V diagnostic criteria, using Hamilton Depressive Table ( HAMD) and Melody Table (BRMS) evaluate the state of psychosis in patients with double-phase emotional disorders; the PNASS meter is used to assess the state of mental illnesses in patients with schizophrenia; using Hamilton Depression Table (HAMD) and Montgomery The depression table (MADRS) evaluates the state of psychiatrical conditions of depression, and the operational norms are unified, and consistency detection meets the requireme...
Embodiment 2
[0127] After the sample of the sample of Example 1, the sample was analyzed by the entire epiton metabolite analysis, and the expression abundance was statistically analyzed.
[0128] 1. Screening significant differences of exossthetic metabolites
[0129] In this embodiment, there are 143 samples of the sample, including 40 healthy controls, 32 dual-phase emotional disorders, 31 depression patients and 40 schizophrenia patients. In this embodiment, a total of 350 extratrial metabolites entered a differential analysis.
[0130] In the present embodiment, the difference analysis was performed using OPLS-DA, and the p-value> 1.0 is a different metabolite, and 38 different metabolites (Table 2) were finally screened. figure 2 The S-PLOT diagram of OPLS-DA analysis is shown in which the horizontal coordinates indicate the coordinate correlation coefficient of the main component and the metabolite, and the ordinate represents the correlation coefficient of the main component and the me...
Embodiment 3
[0134] A random forest algorithm model training for 16 cases of training sets and 12 patients with double-phase emotional disorders, and in the present invention, the present invention further analyzes the exocial metabolism markers from the first batch of data differentially expressing the epigrandotrans, and passed Many analysts were analyzed, and 15 different metabolites were finally screened (Table 3).
[0135] Table 3. Export metabolism markers from the training set screen
[0136]
[0137] Analysis results:
[0138] 1. Screening the proprietary metabolism marker
[0139] The expression of 15 extratrial metabolic markers in the training concentration of the present invention see Table 2. Its ROC curve is like Figure 3A Indicated. 15 extratrial metabolism markers were 83.8% in the training set sample.
[0140] 2. Verify the filtered exosomal metabolism marker
[0141] Through the test set sample verification training set, 15 extratrogen metabolism markers were diagnosed, and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com